New and Evolving Immunotherapy in Inflammatory Bowel Disease
Inflammatory Intestinal Diseases · 2016
DOI: 10.1159/000445986 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammatory Intestinal Diseases, 2016. Verfasst von Mohamad A Raad und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, American University of Beirut, Beirut, Lebanon. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background: Crohn's disease and ulcerative colitis are chronic inflammatory disorders associated with a dysregulated adaptive and innate immune response to gut commensals in genetically susceptible individuals. The pathogenesis of inflammatory bowel disease is complex, and the disease is characterized by significant phenotypic and genotypic heterogeneity. Summary: The introduction of anti-TNF biologics has resulted in improved clinical outcomes in patients with severe and moderately severe disease, but the current treatment paradigm continues to depend on systemic immunosuppression (steroids and immunomodulators) and surgical intervention in a significant number of patients, underscoring a significant unmet need. More recently, a number of genetic and immunologic abnormalities have been unraveled including aberrant intestinal mucosal defense function, abnormal intestinal permeability, dysregulated bacterial antigen processing by macrophages and presentation to T cells, cellular immune regulation and signaling, cytokine production, and leukocyte trafficking. Key Messages: Understanding these molecular mechanisms and effector pathways presents an opportunity for the development of new and improved targeted therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, American University of Beirut, Beirut, Lebanon.
- Division of Gastroenterology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Zitieren
APA
Raad, M. A., Chams, N. H., & Sharara, A. I. (2016). New and Evolving Immunotherapy in Inflammatory Bowel Disease. Inflammatory Intestinal Diseases. https://doi.org/10.1159/000445986
Vancouver
Raad MA, Chams NH, Sharara AI. New and Evolving Immunotherapy in Inflammatory Bowel Disease. Inflammatory Intestinal Diseases. 2016. doi:10.1159/000445986
BibTeX
@article{Raad2016,
author = {Raad, Mohamad A and Chams, Nour H and Sharara, Ala I},
title = {New and Evolving Immunotherapy in Inflammatory Bowel Disease},
journal = {Inflammatory Intestinal Diseases},
year = {2016},
doi = {10.1159/000445986}
}
EUVIMED